Skip to main content

The FDA just approved an Apple Watch app to track Parkinson’s disease

The U.S. Food and Drug Administration (FDA) has given the green light to an Apple Watch app to monitor Parkinson’s disease, developed by San Francisco-based startup Rune Labs. As reported by Reuters, the Apple Watch’s pre-existing sensors can already detect falls, tremors, and other movement disorders consistent with symptoms of Parkinson’s. But Rune Labs has taken things a step further with its app, gathering individual data on the symptoms patients experience so that it can be shared with doctors to determine the best course of treatment.

Brian Pepin, CEO of Rune Labs, said that the data Apple Watch gathers through its Parkinson’s monitoring app will be combined with data from other sources, like brain implants. He also added that the app uses Rune Labs’ StrivePD software to send doctors continuous streams of data to give more context to movement patterns. This provides more data than doctors would get from observing a patient coming in for a short clinical visit, as symptoms of Parkinson’s disease change over time.

App menu on the Apple Watch Series 7.
Andy Boxall/Digital Trends

“When you think about the process of getting someone to their optimal therapy or combination of drugs or devices, or even whether or not a patient might be a good fit for a certain clinical trial, it’s a very hard decision to make when you only have a little context,” Pepin said.

Recommended Videos

Developers have been testing the Apple Watch’s monitoring of Parkinson’s disease ever since Apple introduced its ResearchKit framework in 2015. Originally, this allowed the Apple Watch to track users’ walking gait by prompting them to walk 20 steps every which way. Three years later, Apple updated ResearchKit with the Movement Disorder API, which can detect two common symptoms of Parkinson’s: tremors and dyskinesia, a side-effect of Parkinson’s medications that causes fidgeting and swaying motions.

Please enable Javascript to view this content

The Parkinson’s monitoring app is the second Apple Watch software to receive FDA clearance after the agency cleared AFib History for use in watchOS 9 following its WWDC presentation last week. This feature tells users diagnosed with atrial fibrillation how frequently their heart rhythm shows signs of AFib, which, if left untreated, can cause a stroke and other cardiovascular complications.

Cristina Alexander
Cristina Alexander is a gaming and mobile writer at Digital Trends. She blends fair coverage of games industry topics that…
The Apple Watch Series 10 has ruined smartwatches for me
A person wearing the aluminum Apple Watch Series 10.

That’s it, the Apple Watch Series 10 has ruined other smartwatches for me. This week I will swap to another smartwatch I have to review, but I don’t want to take the Apple Watch off. It's wonderful.

I don’t want to use the word perfect because, of course, it’s not, but it’s very, very close to it. Prepare for some gushing over the next few hundred words, as I’m going to explain why if you’re looking for a smartwatch, the search can stop with the Apple Watch Series 10.
Why don’t I want to take it off?

Read more
I already damaged my Apple Watch Series 10
i already damaged my apple watch series 10 dt 1

I don’t think I’m clumsy, but I swing my arms a lot and still grimace every time a smartwatch on my wrist hits an immovable object. Yet, for all this movement, I’ve never managed to deeply scratch or lightly crack an Apple Watch display … until now.

The Apple Watch Series 10 doesn’t have many compromises over the Apple Watch Ultra 2, and I even made the switch permanently before this happened. It’s big, thin, and beautiful, but the Apple Watch Series 10 also uses a less durable protective shield for its display.

Read more
Blood oxygen tracking isn’t coming back to the Apple Watch anytime soon
Apple Watch Ultra taking a measurement for blood oxygen levels.

One of the major selling points of Apple Watches in recent years has been the ability to test users’ blood oxygen levels. Unfortunately, ongoing litigation has prevented this feature from being included in Apple Watches sold in the U.S. since January. Now, it seems unlikely that this situation will change soon.

On Friday, a Delaware jury found that health-monitoring technology company Masimo infringed on some of Apple’s earlier smartwatch patents. As a result, Apple received an award of only $250. However, the same jury ruled that Masimo's current watches did not infringe on the patents that Apple accused it of copying. Consequently, an injunction remains in effect in the U.S. that prevents the company from offering blood oxygen tracking on new watches sold in the country.

Read more